Robert Wilcox
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Internal Medicine top 10%
Papers in
-
- Antiplatelet Therapy and Cardiovascular Diseases 5
- Acute Myocardial Infarction Research 4
- Heart Failure Treatment and Management 1
- Atrial Fibrillation Management and Outcomes 1
- Surgery 3
- Coronary Interventions and Diagnostics 1
- Co-authors
- Stuart Kupfer (2 shared papers)John Dormandy (2 shared papers)Marie‐Germaine Bousser (1 shared paper)D. J. Betteridge (1 shared paper)Valdis Pīrāgs (1 shared paper)Guntram Schernthaner (1 shared paper)Erland Erdmann (1 shared paper)David A. Morrow (2 shared papers)
- Journals
- Journal of Thrombosis and Thrombolysis (1 paper)Current Medical Research and Opinion (1 paper)European Heart Journal (1 paper)Journal of Cardiac Failure (1 paper)The Lancet (1 paper)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Robert Wilcox
9 papers receiving 659 citations
Peers
Comparison fields: 5 of 58
- Endocrinology, Diabetes and Metabolism 314
- Internal Medicine 51
- Cardiology and Cardiovascular Medicine 301
- Neurology 34
- Hematology 40
Countries citing papers authored by Robert Wilcox
This map shows the geographic impact of Robert Wilcox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Wilcox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Wilcox more than expected).
Fields of papers citing papers by Robert Wilcox
This network shows the impact of papers produced by Robert Wilcox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Wilcox. The network helps show where Robert Wilcox may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Wilcox, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 348 | |
| 2 | 2012 | 150 | |
| 3 | 2008 | 101 | |
| 4 | 2010 | 32 | |
| 5 | 2014 | 15 | |
| 6 | PROactive 07: pioglitazone in the treatment of type 2 diabetes: results of the PROactive study | 2007 | 14 |
| 7 | 2006 | 12 | |
| 8 | 2014 | 5 | |
| 9 | 2000 | 2 |
About Robert Wilcox
Robert Wilcox is a scholar working on Cardiology and Cardiovascular Medicine, Surgery, Endocrinology, Diabetes and Metabolism, Internal Medicine and Molecular Biology, having authored 9 papers that have together received 679 indexed citations. Recurring topics across this work include Antiplatelet Therapy and Cardiovascular Diseases (5 papers), Acute Myocardial Infarction Research (4 papers), Diabetes Treatment and Management (3 papers), Venous Thromboembolism Diagnosis and Management (2 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (1 paper), Coronary Interventions and Diagnostics (1 paper), Heart Failure Treatment and Management (1 paper) and Atrial Fibrillation Management and Outcomes (1 paper). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (314 citations), Internal Medicine (51 citations), Cardiology and Cardiovascular Medicine (301 citations), Neurology (34 citations) and Hematology (40 citations). Robert Wilcox has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Stuart Kupfer, John Dormandy, Marie‐Germaine Bousser, D. J. Betteridge, Valdis Pīrāgs, Guntram Schernthaner, Erland Erdmann, David A. Morrow, Eugene Braunwald and Gaetano Maria De Ferrari. Their work appears in journals such as Journal of Thrombosis and Thrombolysis, Current Medical Research and Opinion, European Heart Journal, Journal of Cardiac Failure and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.